Byun, W.S.; Bae, E.S.; Cui, J.; Park, H.J.; Oh, D.-C.; Lee, S.K.
Antitumor Activity of Pulvomycin via Targeting Activated-STAT3 Signaling in Docetaxel-Resistant Triple-Negative Breast Cancer Cells. Biomedicines 2021, 9, 436.
https://doi.org/10.3390/biomedicines9040436
AMA Style
Byun WS, Bae ES, Cui J, Park HJ, Oh D-C, Lee SK.
Antitumor Activity of Pulvomycin via Targeting Activated-STAT3 Signaling in Docetaxel-Resistant Triple-Negative Breast Cancer Cells. Biomedicines. 2021; 9(4):436.
https://doi.org/10.3390/biomedicines9040436
Chicago/Turabian Style
Byun, Woong Sub, Eun Seo Bae, Jinsheng Cui, Hyen Joo Park, Dong-Chan Oh, and Sang Kook Lee.
2021. "Antitumor Activity of Pulvomycin via Targeting Activated-STAT3 Signaling in Docetaxel-Resistant Triple-Negative Breast Cancer Cells" Biomedicines 9, no. 4: 436.
https://doi.org/10.3390/biomedicines9040436
APA Style
Byun, W. S., Bae, E. S., Cui, J., Park, H. J., Oh, D.-C., & Lee, S. K.
(2021). Antitumor Activity of Pulvomycin via Targeting Activated-STAT3 Signaling in Docetaxel-Resistant Triple-Negative Breast Cancer Cells. Biomedicines, 9(4), 436.
https://doi.org/10.3390/biomedicines9040436